CO4340557A1 - PHARMACEUTICAL FORMULATIONS THAT INCLUDE DERIVATIVES OF THE CLAVULANIC ACID AND ITS USE - Google Patents
PHARMACEUTICAL FORMULATIONS THAT INCLUDE DERIVATIVES OF THE CLAVULANIC ACID AND ITS USEInfo
- Publication number
- CO4340557A1 CO4340557A1 CO95039806A CO95039806A CO4340557A1 CO 4340557 A1 CO4340557 A1 CO 4340557A1 CO 95039806 A CO95039806 A CO 95039806A CO 95039806 A CO95039806 A CO 95039806A CO 4340557 A1 CO4340557 A1 CO 4340557A1
- Authority
- CO
- Colombia
- Prior art keywords
- acid
- combination
- derivative
- reactionable
- carbonate
- Prior art date
Links
Abstract
UNA FORMULACION FARMACEUTICA SOLIDA PARA ADMI- NISTRACION ORAL, QUE COMPRENDE EN COMBINACION CLA- VULANTE Y UN ACIDO ORGANICO FARMACEUTICAMENTE ACEPTABLE O UN DERIVADO SALINO DEL MISMO FARMACEU- TICAMENTE ACEPTABLE O DE COMPONENTES QUE PUEDAN REACCIONAR CONJUNTAMENTE PARA FORMAR DICHO DERIVA- DO SALINO, CON LA EXCLUSION DE: ACIDO SUCCINICO, ACIDO TARTARICO, ACIDO CITRICO O ACIDO MALICO CUANDO ESTOS ACIDOS FORMAN UN COMPONENTE DE UNA PAREJA EFERVESCENTE CON UN CARBONATO DE METAL AL- CALINO O CARBONATO EN UNA TABLETA MASTICABLE; DE LA COMBINACION DE SUCCINATO DE DISODIO Y ACIDO SUCCINICO; Y DE ALMIDON GLICONATO DE SODIO EN UNA RELACION DE ALMIDON GLICONATO DE SODIO: CLAVULA- NATO DE < 1 : 1.4. 2UN METODO PARA LA PREPARACION DE UNA FORMULA- CION FARMACEUTICA DE ACUERDO CON LA REIVINDICACION 1, CUYO METODO COMPRENDE LA INCORPORACION DE LA COMBINACION DE CLAVULANATO Y EL MENCIONADO ACIDO ORGANICO FARMACEUTICAMENTE ACEPTABLE Y/O EL DERI- VADO SALINO FARMACEUTICAMENTE ACEPTABLE DEL MISMO O DE COMPONENTES QUE PUEDAN REACCIONAR CONJUNTA- MENTE PARA FORMAR TAL DERIVADO SALINO, OPCIONAL- MENTE CON UN ANTIBIOTICO.A STRONG PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION, COMPRISING IN A CLAVING COMBINATION AND A PHARMACEUTICALLY ACCEPTABLE ORGANIC ACID OR A SALINE DERIVATIVE OF THE SAME PHARMACEUTICALLY ACCEPTABLE, SUCCESSFUL, AND MAY BE REACTIONABLE, RECIPIENT, AND MAY BE REACTIONABLE. EXCLUSION OF: SUCCINIC ACID, TARTARIC ACID, CITRIC ACID OR MALIC ACID WHEN THESE ACIDS FORM A COMPONENT OF AN EFFERVESCENT COUPLE WITH A CARBONATE OF ALKALINE METAL OR CARBONATE IN A CHEWABLE TABLET; OF THE COMBINATION OF DISODIUM SUCCINATE AND SUCCINIC ACID; AND OF SODIUM GLYCONATE STARCH IN A RATE OF SODIUM STARCH GLYCONATE: CLAVULA- NATO OF <1: 1.4. 2A METHOD FOR THE PREPARATION OF A PHARMACEUTICAL FORMULATION IN ACCORDANCE WITH CLAIM 1, WHICH METHOD INCLUDES THE INCORPORATION OF THE CLAVULANATE COMBINATION AND THE SOCIALLY ACCEPTED FARMACEUTICALLY ACCEPTABLE AND / OR THE DERIVATIVE COMPUTER THAT THEY CAN REACTION TOGETHER TO FORM SUCH A SALINE DERIVATIVE, OPTIONALLY WITH AN ANTIBIOTIC.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CO95039806A CO4340557A1 (en) | 1995-09-01 | 1995-09-01 | PHARMACEUTICAL FORMULATIONS THAT INCLUDE DERIVATIVES OF THE CLAVULANIC ACID AND ITS USE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CO95039806A CO4340557A1 (en) | 1995-09-01 | 1995-09-01 | PHARMACEUTICAL FORMULATIONS THAT INCLUDE DERIVATIVES OF THE CLAVULANIC ACID AND ITS USE |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4340557A1 true CO4340557A1 (en) | 1996-07-30 |
Family
ID=40909487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO95039806A CO4340557A1 (en) | 1995-09-01 | 1995-09-01 | PHARMACEUTICAL FORMULATIONS THAT INCLUDE DERIVATIVES OF THE CLAVULANIC ACID AND ITS USE |
Country Status (1)
Country | Link |
---|---|
CO (1) | CO4340557A1 (en) |
-
1995
- 1995-09-01 CO CO95039806A patent/CO4340557A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1245761B (en) | PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY. | |
ATE151285T1 (en) | ORAL MEDICINAL PRODUCTS WITH COLON-SPECIFIC RELEASE | |
AU2584192A (en) | Bone-growth-stimulating composition | |
LU90677I2 (en) | Esomeprazole and its pharmaceutically acceptable salts and derivatives (nexiam) | |
ITFI930247A1 (en) | ANTAGONISTS OF TACHYCININS, PROCEDURE FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL FORMULATIONS. | |
IL111519A0 (en) | Sustained release tablets having an insoluble active ingredient therein and methods for the preparation thereof | |
DE69105040T2 (en) | Medicines for impotence. | |
LTIP1722A (en) | Therapeutically active substituted benzimidazole and process for its preparation | |
IL92799A0 (en) | Benzimidazole derivatives with gastric acid inhibition and process for its preparation | |
EP0302714A3 (en) | Pharmaceutical composition for treatment of bone-wasting diseases | |
NO950134L (en) | Formulations for orally administered pharmaceutical agents | |
CO4340557A1 (en) | PHARMACEUTICAL FORMULATIONS THAT INCLUDE DERIVATIVES OF THE CLAVULANIC ACID AND ITS USE | |
DE69103724T2 (en) | PHARMACEUTICAL COMPOSITIONS WITH DELAYED RELEASE FOR ORAL ADMINISTRATION AND THEIR PRODUCTION METHOD. | |
AR003408A1 (en) | CLAVULANATE SALT WITH BENZIDRILAMINE, PREPARATION PROCESS AND PHARMACEUTICAL FORMULATION CONTAINING IT. | |
ES8303915A1 (en) | Pharmaceutical composition of phosphonomicin in tablet form. | |
AU560185B2 (en) | Penicillin derivatives | |
ATE181828T1 (en) | ORAL MEDICINAL PRODUCT CONSISTING OF IBUPROFEN | |
IT1238205B (en) | For of oral administration of creatine phosphate and relative pharmaceutical composition | |
CO4370015A1 (en) | PHARMACEUTICAL FORMULATION UNDERSTANDING AMOXICILLIN AND POTASSIUM OF CLAVULANATE |